Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies
Top Cited Papers
Open Access
- 13 June 2012
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 4 (138), 138ra81
- https://doi.org/10.1126/scitranslmed.3003876
Abstract
Macaques survived infection with Ebola virus when treated starting at 24 hours after infection with mix of three neutralizing monoclonal antibodies.Keywords
This publication has 34 references indexed in Scilit:
- Replication, Pathogenicity, Shedding, and Transmission of Zaire ebolavirus in PigsThe Journal of Infectious Diseases, 2011
- Recent advances inEbolavirusvaccine developmentHuman Vaccines, 2010
- Disease modeling for Ebola and Marburg virusesDisease Models & Mechanisms, 2009
- Recombinant Human Activated Protein C for the Postexposure Treatment of Ebola Hemorrhagic FeverThe Journal of Infectious Diseases, 2007
- Effective Post-Exposure Treatment of Ebola InfectionPLoS Pathogens, 2007
- Severe protein C deficiency predicts early death in severe sepsisCritical Care Medicine, 2004
- Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeysThe Lancet, 2003
- Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key EventThe Journal of Infectious Diseases, 2003
- Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsisCritical Care Medicine, 2001
- Ebola haemorrhagic fever: experimental infection of monkeysTransactions of the Royal Society of Tropical Medicine and Hygiene, 1978